Cardizem CD (diltiazem HCl) capsules, 300 mg, packaged in a) 30-count bottles (NDC 0187-0798-30); and b) 90-count bottles (NDC 0187-0798-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.
Published February 20, 2019 · Recall initiated: January 30, 2019
Summary
FDA records drug Class III recall D-0490-2019, published February 20, 2019 and initiated January 30, 2019. Recalling firm: Valeant Pharmaceuticals North America LLC; Status: Terminated; Reported quantity: 22 bottles; Lot: Lots: a)18J020P, Exp 08/2020; b) 18J034P, Exp 08/2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.
What to do
Voluntary: Firm initiated · Letter
Get an email if CARDIZEM CD has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CARDIZEM CD
- Manufacturer
- Valeant Pharmaceuticals North America LLC
- Distributor
- Nationwide in the USA and Puerto Rico
- UPC
- 0301870796421
- Lot
- Lots: a)18J020P, Exp 08/2020; b) 18J034P, Exp 08/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACardizem CD (diltiazem HCl) capsules, 120 mg, packaged in a) 30-count bottles (NDC 0187-0795-30); and b)February 20, 2019
- FDACardizem CD (diltiazem HCl) capsules, 180 mg, packaged in a) 30-count bottles (NDC 0187-0796-30); and b)February 20, 2019
- FDADiltiazem HCl CD capsules, 360 mg, 90-count bottles, Rx Only, Manufactured for: Oceanside Pharmaceuticals, aFebruary 20, 2019
- FDAClobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Macleods Pharma USA,February 20, 2019
- FDACOSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle,February 20, 2019
- FDAInfants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free,February 20, 2019
Questions about this recall
Was Cardizem CD (diltiazem HCl) capsules, 300 mg, packaged in a) 30-count bottles (NDC 0187-0798-30); and b) 90-count bottles (NDC 0187-0798-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada. recalled?
Yes. FDA published recall D-0490-2019 on February 20, 2019. Reported hazard: Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CARDIZEM CD. UPC: 0301870796421.